UniProt ID | WASP_HUMAN | |
---|---|---|
UniProt AC | P42768 | |
Protein Name | Wiskott-Aldrich syndrome protein | |
Gene Name | WAS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 502 | |
Subcellular Localization | Cytoplasm, cytoskeleton. | |
Protein Description | Effector protein for Rho-type GTPases. Regulates actin filament reorganization via its interaction with the Arp2/3 complex. Important for efficient actin polymerization. Possible regulator of lymphocyte and platelet function. Mediates actin filament reorganization and the formation of actin pedestals upon infection by pathogenic bacteria.. | |
Protein Sequence | MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSGGPMGGR ------CCCCCCCCC | 53.08 | 23401153 | |
45 | Phosphorylation | MLGRKCLTLATAVVQ HHHHHHHHHHHHHHH | 24.66 | 20049867 | |
54 | Phosphorylation | ATAVVQLYLALPPGA HHHHHHHHHHCCCCC | 3.48 | 20049867 | |
76 | Sumoylation | CGAVCFVKDNPQKSY CCCEEEECCCCCCEE | 31.38 | - | |
76 | Ubiquitination | CGAVCFVKDNPQKSY CCCEEEECCCCCCEE | 31.38 | - | |
76 | Sumoylation | CGAVCFVKDNPQKSY CCCEEEECCCCCCEE | 31.38 | - | |
81 | Ubiquitination | FVKDNPQKSYFIRLY EECCCCCCEEEEEHH | 48.67 | - | |
83 | Phosphorylation | KDNPQKSYFIRLYGL CCCCCCEEEEEHHHH | 15.29 | - | |
88 | Phosphorylation | KSYFIRLYGLQAGRL CEEEEEHHHHHHHHH | 13.12 | 30257219 | |
102 | Phosphorylation | LLWEQELYSQLVYST HHHHHHHHHHHHHCC | 8.13 | - | |
144 | Sumoylation | FRALVQEKIQKRNQR HHHHHHHHHHHHHHH | 33.09 | - | |
144 | Ubiquitination | FRALVQEKIQKRNQR HHHHHHHHHHHHHHH | 33.09 | 21890473 | |
144 | Sumoylation | FRALVQEKIQKRNQR HHHHHHHHHHHHHHH | 33.09 | - | |
147 | Acetylation | LVQEKIQKRNQRQSG HHHHHHHHHHHHHCC | 57.71 | 25953088 | |
147 | Sumoylation | LVQEKIQKRNQRQSG HHHHHHHHHHHHHCC | 57.71 | - | |
147 | Sumoylation | LVQEKIQKRNQRQSG HHHHHHHHHHHHHCC | 57.71 | - | |
147 | Ubiquitination | LVQEKIQKRNQRQSG HHHHHHHHHHHHHCC | 57.71 | - | |
194 | Phosphorylation | GPPVGPLSLGLATVD CCCCCCCEEEEEEEE | 24.43 | 29438985 | |
210 | Phosphorylation | QNPDITSSRYRGLPA CCCCCCCCCCCCCCC | 25.36 | 29438985 | |
212 | Phosphorylation | PDITSSRYRGLPAPG CCCCCCCCCCCCCCC | 15.81 | 27155012 | |
221 | Phosphorylation | GLPAPGPSPADKKRS CCCCCCCCHHHHCCC | 38.34 | 23401153 | |
234 | Phosphorylation | RSGKKKISKADIGAP CCCCCCCCHHHCCCC | 30.58 | 30108239 | |
235 | Ubiquitination | SGKKKISKADIGAPS CCCCCCCHHHCCCCC | 54.26 | - | |
277 | Phosphorylation | LFSRAGISEAQLTDA HHHHHCCCHHHCCCH | 26.43 | 28450419 | |
282 | Phosphorylation | GISEAQLTDAETSKL CCCHHHCCCHHHHHH | 22.53 | 28450419 | |
286 | Phosphorylation | AQLTDAETSKLIYDF HHCCCHHHHHHHHHH | 32.65 | 28450419 | |
287 | Phosphorylation | QLTDAETSKLIYDFI HCCCHHHHHHHHHHH | 19.57 | 28450419 | |
291 | Phosphorylation | AETSKLIYDFIEDQG HHHHHHHHHHHHHCC | 18.42 | 16472662 | |
320 | Phosphorylation | LPPPPPPSRGGNQLP CCCCCCCCCCCCCCC | 49.70 | - | |
321 | Methylation | PPPPPPSRGGNQLPR CCCCCCCCCCCCCCC | 63.91 | 115385621 | |
328 | Methylation | RGGNQLPRPPIVGGN CCCCCCCCCCCCCCC | 59.21 | 115385627 | |
338 | Methylation | IVGGNKGRSGPLPPV CCCCCCCCCCCCCCC | 39.80 | 52723715 | |
339 | Phosphorylation | VGGNKGRSGPLPPVP CCCCCCCCCCCCCCC | 54.13 | 27080861 | |
355 | Phosphorylation | GIAPPPPTPRGPPPP CCCCCCCCCCCCCCC | 31.24 | 27080861 | |
357 | Methylation | APPPPTPRGPPPPGR CCCCCCCCCCCCCCC | 73.12 | 115391857 | |
357 | Dimethylation | APPPPTPRGPPPPGR CCCCCCCCCCCCCCC | 73.12 | - | |
364 | Methylation | RGPPPPGRGGPPPPP CCCCCCCCCCCCCCC | 53.31 | 16287795 | |
364 | Dimethylation | RGPPPPGRGGPPPPP CCCCCCCCCCCCCCC | 53.31 | - | |
377 | Methylation | PPPPATGRSGPLPPP CCCCCCCCCCCCCCC | 33.80 | 115391853 | |
431 | Methylation | GLAPGGGRGALLDQI CCCCCCCHHHHHHHH | 30.41 | 115385633 | |
439 | Methylation | GALLDQIRQGIQLNK HHHHHHHHHHHCCCC | 24.04 | 115385639 | |
483 | Phosphorylation | KRSRAIHSSDEGEDQ HHHHHHHCCCCCCCC | 33.11 | 28674151 | |
484 | Phosphorylation | RSRAIHSSDEGEDQA HHHHHHCCCCCCCCC | 26.06 | 7753869 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
102 | Y | Phosphorylation | Kinase | NPM-ALK | AAA58698 | PSP |
291 | Y | Phosphorylation | Kinase | NPM-ALK | AAA58698 | PSP |
291 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
291 | Y | Phosphorylation | Kinase | TNK2 | Q07912 | GPS |
291 | Y | Phosphorylation | Kinase | BTK | Q06187 | PhosphoELM |
291 | Y | Phosphorylation | Kinase | FYN | P06241 | Uniprot |
291 | Y | Phosphorylation | Kinase | HCK | P08631 | Uniprot |
291 | Y | Phosphorylation | Kinase | HCK | P08103 | PSP |
291 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
291 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
483 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
483 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
483 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
484 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
484 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
484 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WASP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WASP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
301000 | Wiskott-Aldrich syndrome (WAS) | |||||
313900 | Thrombocytopenia 1 (THC1) | |||||
300299 | Neutropenia, severe congenital, X-linked (XLN) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291; SER-483 ANDSER-484, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291; SER-483 ANDSER-484, AND MASS SPECTROMETRY. | |
"Phosphorylation of the WASP-VCA domain increases its affinity for theArp2/3 complex and enhances actin polymerization by WASP."; Cory G.O.C., Cramer R., Blanchoin L., Ridley A.J.; Mol. Cell 11:1229-1239(2003). Cited for: PHOSPHORYLATION AT SER-483 AND SER-484, AND INTERACTION WITH THEARP2/3 COMPLEX. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-291, AND MASSSPECTROMETRY. | |
"Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndromeprotein (WASp) tyrosine phosphorylation is required for coupling Tcell antigen receptor engagement to WASp effector function and T cellactivation."; Badour K., Zhang J., Shi F., Leng Y., Collins M., Siminovitch K.A.; J. Exp. Med. 199:99-112(2004). Cited for: PHOSPHORYLATION AT TYR-291 BY FYN. | |
"Phosphorylation of tyrosine 291 enhances the ability of WASp tostimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein."; Cory G.O., Garg R., Cramer R., Ridley A.J.; J. Biol. Chem. 277:45115-45121(2002). Cited for: FUNCTION, PHOSPHORYLATION AT TYR-291 BY HCK, MASS SPECTROMETRY, ANDINTERACTION WITH HCK. |